Deutsch English Français

Contact

EP2124923

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2124923

EP2124923 - USE OF A POLYPHENOL IN THE TREATMENT OF THE METABOLIC SYNDROME AND ENDOTHELIAL DYSFUNCTION OR OTHER VASCULAR SEQUELLAE. [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 09.06.2017 Database last updated on 14.09.2024
Former	Examination is in progress Status updated on 23.02.2017
Most recent event Tooltip	09.06.2017	Application deemed to be withdrawn	published on 12.07.2017 [2017/28]
Applicant(s)	For all designated states Imagination Unlimited B.V. Wolfhezerweg 11 6761 AA Oosterbeek / NL
	[2009/49]
Representative(s)	HGF HGF Limited Mill House North Street York YO1 6JD / GB
	[N/P]
Former [2012/47]	Harrison Goddard Foote Saviour House 9 St. Saviourgate York YO1 8NQ / GB
Former [2012/08]	Heezius, Anke E. Life Sciences Legal Advocaten B.V. Frans van Mierisstraat 55/11 1070 RK Amsterdam / NL
Former [2009/49]	Heezius, Anke E. SteinhauserVandenBrinkHeeziusRijsdijk Advocaten Strawinskylaan 1347 NL-1077 XX Amsterdam / NL
Application number, filing date	07725896.0	07.06.2007
	[2009/49]
	WO2007EP05050
Priority number, date	EP20060076180	07.06.2006 Original published format: EP 06076180
	[2009/49]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2007141026
	Date:	13.12.2007
	Language:	EN
	[2007/50]
	Type:	A1 Application with search report
	No.:	EP2124923
	Date:	02.12.2009
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 13.12.2007 takes the place of the publication of the European patent application.
	[2009/49]
Search report(s)	International search report - published on:	EP	13.12.2007
Classification	IPC:	A61K31/202, A61K36/87, A61K36/73, A61K36/45, A61P3/10, A61P9/10, A61K36/33, A61K131/00	[2009/49]
	CPC:	A61K36/33 (EP,US); A23L19/00 (EP,US); A23L19/09 (EP,US); A23L33/105 (EP,US); A23L33/12 (EP,US); A61K31/202 (EP,US); (+) A61K36/45 (EP,US); A61K36/73 (EP,US); A61K36/87 (EP,US); A61P3/10 (EP); A61P9/10 (EP) (-)
	C-Set:	A61K31/202, A61K2300/00 (EP,US); A61K36/33, A61K2300/00 (US,EP); A61K36/45, A61K2300/00 (US,EP); A61K36/73, A61K2300/00 (US,EP); (+) A61K36/87, A61K2300/00 (EP,US) (-)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2009/49]
Title	German:	VERWENDUNG EINES POLYPHENOLS BEI DER BEHANDLUNG DES METABOLISCHEN SYNDROMS UND VON ENDOTHEL-DYSFUNKTION ODER ANDEREN VASKULÄREN FOLGEN	[2009/49]
	English:	USE OF A POLYPHENOL IN THE TREATMENT OF THE METABOLIC SYNDROME AND ENDOTHELIAL DYSFUNCTION OR OTHER VASCULAR SEQUELLAE.	[2009/49]
	French:	UTILISATION D'UN POLYPHÉNOL POUR LE TRAITEMENT DU SYNDROME MÉTABOLIQUE ET D'UN DYSFONCTIONNEMENT ENDOTHÉLIAL OU D'AUTRES SÉQUELLES VASCULAIRES	[2009/49]
Entry into regional phase	08.12.2008	National basic fee paid
	04.08.2009	Designation fee(s) paid
	08.12.2008	Examination fee paid
Examination procedure	08.12.2008	Examination requested [2009/49]
	10.12.2009	Despatch of a communication from the examining division (Time limit: M04)
	14.04.2010	Reply to a communication from the examining division
	07.06.2010	Despatch of a communication from the examining division (Time limit: M04)
	22.07.2010	Observations by third parties
	01.10.2010	Reply to a communication from the examining division
	15.12.2010	Despatch of a communication from the examining division (Time limit: M04)
	14.04.2011	Reply to a communication from the examining division
	07.09.2011	Despatch of a communication from the examining division (Time limit: M04)
	30.12.2011	Reply to a communication from the examining division
	05.07.2012	Date of oral proceedings
	27.07.2012	Despatch of communication that the application is refused, reason: substantive examination {1}
	27.07.2012	Minutes of oral proceedings despatched
	03.01.2017	Application deemed to be withdrawn, date of legal effect [2017/28]
	24.02.2017	Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2017/28]
Appeal following examination	26.09.2012	Appeal received No. T0320/13
	06.12.2012	Statement of grounds filed
	08.05.2017	Result of appeal procedure: the application was deemed to be withdrawn
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 10.12.2009
Request for further processing for:	The application is deemed to be withdrawn due to non-payment of designation fees TR, SK, SI, SE, RO, PT, PL, NL, MT, MC, LV, LU, LT, IT, IS, IE, HU, GR, GB, FR, FI, ES, EE, DK, DE, CZ, CY, CH, BG, BE, AT
	17.08.2009	Request for further processing filed
	17.08.2009	Full payment received (date of receipt of payment)
Fees paid	Renewal fee
	24.12.2009	Renewal fee patent year 03
	31.12.2010	Renewal fee patent year 04
	29.12.2011	Renewal fee patent year 05
	14.12.2012	Renewal fee patent year 06
	21.05.2013	Renewal fee patent year 07
	23.05.2014	Renewal fee patent year 08
	01.04.2015	Renewal fee patent year 09
	Penalty fee
	Additional fee for renewal fee
	30.06.2009	03 M06 Fee paid on 24.12.2009
	30.06.2010	04 M06 Fee paid on 31.12.2010
	30.06.2011	05 M06 Fee paid on 29.12.2011
	30.06.2012	06 M06 Fee paid on 14.12.2012
	30.06.2016	10 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[DXY]EP1640001 (NEW PHARMA INVEST HOLDING [LU]) [DX] 1-13 * paragraph [0030] * * paragraph [0020] * * claims 4-13,17,19,20,24,26,27 * * table 1 * [Y] 1-13;
		[PXY]WO2006083666 (A M TODD COMPANY [US], et al) [PX] 1-8,10-13 * claims 1,4,27,31 * * page 24, line 92 * * claims 1,4,6 * [PY] 9;
		[Y]WO2004028469 (MARTEK BIOSCIENCES CORP [US], et al) [Y] 1-13 * abstract *;
		[DXY]DE20304752U (WEBER & WEBER GMBH & CO KG [DE]) [DX] 11-13 * page 15, lines 1-11 * * page 8, columns 19-28 * * examples 26,27 * [Y] 1-13;
		[YD]EP1586244 (COGNIS IP MAN GMBH [DE]) [YD] 1-13 * table 1 * * claims 1-8 * * page 5, line 15 - page 6, line 43 *;
		[DXY]WO2005099483 (VENTURI DAVID [CA], et al) [DX] 1-8,11-13 * claims 1,4,5,14 * * paragraphs [0017] - [0019] * [Y] 1-11,9;
		[PX]WO2007038685 (CONSTELLATION BRANDS INC [US], et al) [PX] 1-4,9-13 * the whole document *;
		[PX]WO2007038768 (UNIV CALIFORNIA [US], et al) [PX] 1-4,9-13 * the whole document *;
		[DY]WO02082930 (BIO SERAE LABORATOIRES [FR], et al) [DY] 5,6,8,10,11 * claims 25-30 *
		[Y] - MORGAN ET AL, "Effects of Dietary Omega-3 Fatty Acid Supplementation on Endothelium-Dependent Vasodilation in Patients With Chronic Heart Failure", AMERICAN JOURNAL OF CARDIOLOGY, CAHNERS PUBLISHING CO., NEWTON, MA,, US, (20060215), vol. 97, no. 4, ISSN 0002-9149, pages 547 - 551, XP005281267 [Y] 5-7 * abstract * DOI: http://dx.doi.org/10.1016/j.amjcard.2005.08.075
	Examination	- ZENEBE W ET AL, "PROTECTIVE EFFECTS OF RED WINE POLYPHENOLIC COMPOUNDS ON THE CARDIOVASCULAR SYSTEM", EXPERIMENTAL AND CLINICAL CARDIOLOGY, PULSUS GROUP, OAKVILLE, CA, (20010921), vol. 6, no. 3, ISSN 1205-6626, pages 153 - 158, XP001180037
		- BROEKHUIZEN LYSETTE N ET AL, "Reduction of monocyte chemoattractant protein 1 and macrophage migration inhibitory factor by a polyphenol-rich extract in subjects with clustered cardiometabolic risk factors.", THE BRITISH JOURNAL OF NUTRITION NOV 2011 LNKD- PUBMED:21733322, (201111), vol. 106, no. 9, ISSN 1475-2662, pages 1416 - 1422
	other	- "Nuskha Rubb-e-Seb", TKDL, Database accession no. JA7/150, XP003027356
		- MOHAMMAD AZAM KHAN, Muheet-e-Azam, (1887), vol. III, page 86
		- "Nuskha-e-dawa", TKDL, Database accession no. AH3/4005, XP003027357
		- AKLI IBN-E-ABBAAS MAJOOSI, Kaamil-al-Sena'ah, (2005), vol. II, page 409
		- "Nushka-e-Aanaar Bara-e-Ziabetus", TKDL, Database accession no. BA3/1453C, XP003027358
		- MOHAMMAD AKMAL KHAN, Qaraabaadeen Azam wa Akmal, (1967), page 273
		- "Majoon Nukra", TKDL, Database accession no. RS22/1022, XP003027359
		- Rasatantrasarah Evam Siddhaprayogasamgrahah, (1990), vol. I, pages 800 - 801

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p